financetom
Business
financetom
/
Business
/
Update: Guess? Shares Soar After Fiscal Q4 Outperformance, Special Dividend Payout
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Update: Guess? Shares Soar After Fiscal Q4 Outperformance, Special Dividend Payout
Mar 21, 2024 10:04 AM

12:40 PM EDT, 03/21/2024 (MT Newswires) -- (Updates with Thursday's stock price movement in the headline and first paragraph.)

Guess? (GES) shares were up more than 22% in recent Thursday trading following its better-than-expected Q4 performance and a special dividend payout.

Late Wednesday, the company reported fiscal Q4 adjusted earnings of $2.01 per diluted share, up from $1.74 a year earlier.

Analysts polled by Capital IQ expected $1.57.

Revenue for the quarter that ended Feb. 3 was $891.1 million, up from $817.8 million a year earlier.

Analysts surveyed by Capital IQ expected $854.6 million.

The company expects a Q1 adjusted loss of $0.41 to $0.37 per share on revenue growth of 1% to 2%. Analysts polled by Capital IQ expected a loss of $0.02 on sales of $573.1 million.

The company expects fiscal 2025 adjusted EPS of $2.56 to $3.00 on revenue growth of 11.5% to 13.5%. Analysts polled by Capital IQ expected earnings of $2.97 on sales of $2.84 billion.

The company said its board has approved a special dividend of $2.25 per share and a quarterly dividend of $0.30 per share, both payable on May 3 to shareholders of record April 17.

Price: 31.71, Change: +5.76, Percent Change: +22.20

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Sarepta Therapeutics Poised for 'Significant Launch Inflection' Amid Positive Elevidys Feedback, RBC Says
Sarepta Therapeutics Poised for 'Significant Launch Inflection' Amid Positive Elevidys Feedback, RBC Says
Jul 29, 2024
11:41 AM EDT, 07/29/2024 (MT Newswires) -- Sarepta Therapeutics' ( SRPT ) Elevidys, a gene therapy for the treatment of Duchenne muscular dystrophy, or DMD, has drawn high interest from physicians and patients, RBC Capital Markets said in a report Monday. The investment firm also said concerns around treatment throughput, center capacity, and manufacturing supply seem to be overdone following...
Permian Resources Prices Common Stock Offering
Permian Resources Prices Common Stock Offering
Jul 29, 2024
11:40 AM EDT, 07/29/2024 (MT Newswires) -- Permian Resources ( PR ) said Monday it priced a public offering of 26.5 million class A common shares at $15.30 apiece. Concurrently with the offering, the company's Permian Resources Operating unit plans a private placement of $750 million of senior unsecured notes due 2033. Permian Resources ( PR ) said the equity...
Update: Collective Mining Gains 3.6% as It Reports Latest Assays from the Trap Target in Colombia
Update: Collective Mining Gains 3.6% as It Reports Latest Assays from the Trap Target in Colombia
Jul 29, 2024
11:43 AM EDT, 07/29/2024 (MT Newswires) -- Collective Mining ( CNL ) on Monday reported assays for four holes drilled at the Trap target within the company's Guayabales project in Colombia. Highlights include 40.85 meters at 3.76 grams per tonne (g/t) gold equivalent within 174.45 meters at 1.19 gold equivalent. The company said the Trap target can rapidly evolve through...
Microsoft Poised for 'Robust' Fiscal Q4 Results Amid Cloud, AI Momentum, Wedbush Says
Microsoft Poised for 'Robust' Fiscal Q4 Results Amid Cloud, AI Momentum, Wedbush Says
Jul 29, 2024
11:41 AM EDT, 07/29/2024 (MT Newswires) -- Microsoft's ( MSFT ) checks point to another robust quarterly report, with growing artificial intelligence adoption likely accelerating cloud deal flow for its Azure business and strong momentum seen ahead, Wedbush Securities said Monday. We would expect a solid beat for the June quarter with Nadella & Co. likely exceeding the Street's top-line...
Copyright 2023-2026 - www.financetom.com All Rights Reserved